share_log

Revance Therapeutics Down Over 21%, on Pace for Largest Percent Decrease Since October 2021 -- Data Talk

Revance Therapeutics Down Over 21%, on Pace for Largest Percent Decrease Since October 2021 -- Data Talk

Revance Therapeutics下跌超過21%,有望創下自2021年10月以來的最大跌幅——數據談話
道瓊斯 ·  05/10 14:35

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論